{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:29:47Z","timestamp":1762640987453},"reference-count":38,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.cccn.2004.07.023","type":"journal-article","created":{"date-parts":[[2004,9,30]],"date-time":"2004-09-30T15:17:26Z","timestamp":1096557446000},"page":"159-165","source":"Crossref","is-referenced-by-count":11,"title":["Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation"],"prefix":"10.1016","volume":"350","author":[{"given":"Enzo","family":"Emanuele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Peros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piercarlo","family":"Minoretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"D'Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenza","family":"Montagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colomba","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Geroldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cccn.2004.07.023_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00041433-199904000-00007","article-title":"Genetic architecture and evolution of the lipoprotein(a) trait","volume":"10","author":"Utermann","year":"1999","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.cccn.2004.07.023_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0009-3084(94)90148-1","article-title":"Hypervariable polymorphism of APO(a) in blacks and whites as reflected by phenotyping","volume":"67\u201368","author":"Kamboh","year":"1994","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.cccn.2004.07.023_bib3","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1006\/bbrc.1993.1343","article-title":"Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites","volume":"191","author":"Marcovina","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cccn.2004.07.023_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0021-9150(03)00143-6","article-title":"Analysis of the apo(a) size polymorphism in Asian Indian populations: association with Lp(a) concentration and coronary heart disease","volume":"169","author":"Geethanjali","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cccn.2004.07.023_bib5","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jama.276.7.544","article-title":"Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study","volume":"276","author":"Bostom","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.cccn.2004.07.023_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/clinchem\/36.1.20","article-title":"Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age","volume":"36","author":"Sandkamp","year":"1990","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cccn.2004.07.023_bib7","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1161\/01.CIR.74.4.758","article-title":"Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography","volume":"74","author":"Dahlen","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.cccn.2004.07.023_bib8","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJM199005243222104","article-title":"Relation of serum lipoprotein(a) and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia","volume":"322","author":"Seed","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cccn.2004.07.023_bib9","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI115645","article-title":"Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of apo(a) gene in coronary heart disease","volume":"89","author":"Sandholzer","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cccn.2004.07.023_bib10","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.CIR.100.11.1154","article-title":"Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study","volume":"100","author":"Kronenberg","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cccn.2004.07.023_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1749-6632.2001.tb03514.x","article-title":"Inhibition of fibrinolysis by lipoprotein(a)","volume":"936","author":"Angles-Cano","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cccn.2004.07.023_bib12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0002-9149(98)00917-5","article-title":"Correlation of serum lipoprotein(a) with the angiographic and clinical presentation of coronary artery disease","volume":"83","author":"Dangas","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cccn.2004.07.023_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/hrt.53.4.363","article-title":"Plaque fissuring\u2014the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina","volume":"53","author":"Davies","year":"1985","journal-title":"Br. Heart J."},{"key":"10.1016\/j.cccn.2004.07.023_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00043798-200110000-00011","article-title":"Serum lipoprotein(a) concentrations and apolipoprotein(a) isoforms: association with the severity of clinical presentation in patients with coronary heart disease","volume":"8","author":"Katsouras","year":"2001","journal-title":"J. Cardiovasc. Risk"},{"key":"10.1016\/j.cccn.2004.07.023_bib15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0735-1097(96)00560-8","article-title":"Correlation of angiographic morphology and clinical presentation in unstable angina","volume":"29","author":"Dangas","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cccn.2004.07.023_bib16","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/01.CIR.103.15.1955","article-title":"Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes","volume":"103","author":"Ehara","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cccn.2004.07.023_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0735-1097(00)01097-4","article-title":"Impact of coronary artery remodeling on clinical presentation of coronary artery disease: an intravascular ultrasound study","volume":"37","author":"Nakamura","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cccn.2004.07.023_bib18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/01.CIR.80.2.410","article-title":"Unstable angina: a classification","volume":"80","author":"Braunwald","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.cccn.2004.07.023_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0009-8981(93)90030-8","article-title":"Characterization of apo(a) polymorphism by a modified immunoblotting technique in an Italian population sample","volume":"221","author":"Geroldi","year":"1993","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cccn.2004.07.023_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000077293","article-title":"Lipoprotein(a)-associated atherothrombotic risk in hemodialysis patients","volume":"24","author":"Emanuele","year":"2004","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.cccn.2004.07.023_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000079200","article-title":"Relation of apolipoprotein(a) size to Alzheimer's disease and vascular dementia","volume":"18","author":"Emanuele","year":"2004","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.cccn.2004.07.023_bib22","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/oby.2004.166","article-title":"Association between low molecular weight apolipoprotein(a) isoforms and obesity in Italian women","volume":"12","author":"Derosa","year":"2004","journal-title":"Obes. Res."},{"key":"10.1016\/j.cccn.2004.07.023_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neulet.2003.09.046","article-title":"Association between small apolipoprotein(a) isoforms and frontotemporal dementia in humans","volume":"353","author":"Emanuele","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cccn.2004.07.023_bib24","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1681\/ASN.V1051027","article-title":"The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: a prospective follow-up","volume":"10","author":"Kronenberg","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cccn.2004.07.023_bib25","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.277.21.1689","article-title":"Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension","volume":"277","author":"Sechi","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.cccn.2004.07.023_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1681\/ASN.V61110","article-title":"Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis","volume":"6","author":"Kronenberg","year":"1995","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cccn.2004.07.023_bib27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF00220066","article-title":"The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration","volume":"90","author":"Kraft","year":"1992","journal-title":"Hum. Genet."},{"key":"10.1016\/j.cccn.2004.07.023_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1056-8727(02)00192-7","article-title":"Lipoprotein(a), apolipoprotein(a) polymorphism and restenosis after intracoronary stent placement in Type 2 diabetic patients","volume":"17","author":"Gazzaruso","year":"2003","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.cccn.2004.07.023_bib29","first-page":"243","article-title":"Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease","volume":"13","author":"Peros","year":"2004","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cccn.2004.07.023_bib30","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.V8121889","article-title":"Apolipoprotein, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients","volume":"8","author":"Koch","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cccn.2004.07.023_bib31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1172\/JCI115855","article-title":"Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations","volume":"90","author":"Boerwinkle","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cccn.2004.07.023_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2362.2003.01114.x","article-title":"Functional approach to investigate Lp(a) in ischaemic heart and cerebral diseases","volume":"33","author":"de la Pena-Diaz","year":"2003","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.cccn.2004.07.023_bib33","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1161\/01.CIR.96.8.2514","article-title":"Apolipoprotein(a) induces monocyte chemotactic activity in human vascular endothelial cells","volume":"96","author":"Poon","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cccn.2004.07.023_bib34","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/01.CIR.90.2.775","article-title":"Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture","volume":"90","author":"Moreno","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.cccn.2004.07.023_bib35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1464-5491.2001.00536.x","article-title":"Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects","volume":"18","author":"Gazzaruso","year":"2003","journal-title":"Diabet. Med."},{"key":"10.1016\/j.cccn.2004.07.023_bib36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00043798-199802000-00005","article-title":"Apolipoprotein(a) phenotypes and their predictive value for coronary heart disease: identification of an operative cut-off of apolipoprotein(a) polymorphism","volume":"5","author":"Gazzaruso","year":"1998","journal-title":"J. Cardiovasc. Risk"},{"key":"10.1016\/j.cccn.2004.07.023_bib37","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.jacc.2003.08.066","article-title":"High lipoprotein(a) levels and small apolipoprotein(a) sizes are associated with endothelial dysfunction in a multiethnic cohort","volume":"43","author":"Wu","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cccn.2004.07.023_bib38","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/01.ATV.13.7.1037","article-title":"Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study","volume":"13","author":"Marcovina","year":"1993","journal-title":"Arterioscler. Thromb."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898104003845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898104003845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T02:43:56Z","timestamp":1624675436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898104003845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":38,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0009898104003845"],"URL":"https:\/\/doi.org\/10.1016\/j.cccn.2004.07.023","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}